Table 4.
Author | Study Type | Year | Laser | Therapy Parameters | Fitzpatrick Scale | No. of Cases | Clinical Outcome | Adverse Events |
---|---|---|---|---|---|---|---|---|
Sirithanabadeekul et al. [47] | RCT | 2022 | Fractionated 1064-nm picosecond lasers and unfractional 1064-nm ps-laser | 1064-nm ps-laser: fluence 1.5–7.24 J/cm2; 3–4.5 mm spot, 2–5 Hz; fractionated 1064-nm ps-lasers: fluence 0.8 J/cm2; 8 mm spot, 2–5 Hz | III–V | 11 | The combination side showed greater clearance scores and fewer adverse events than the side of unfractional 1064-nm picosecond laser alone. | Temporary crusting, purpura, edema, erythema, burning sensation, and petechiae |
Kasai et al. [45] | Retrospective case series | 2017 | Multi-colored tattoos with a ps 755 nm Alexandrite laser and a ps Nd:YAG laser | / | / | 4 | Ps-lasers require fewer sessions than ns-QS lasers for treating black-colored tattoos and are more efficient than ns-QS lasers for multi-colored tattoos. | Transient PIH in 1 patient |
Kauvar et al. [49] | Prospective clinical study | 2017 | Dual-wavelength, 1064/532-nm, ps-laser | Both wavelengths are used on the same tattoo. Spot sizes 2 to 6 mm, maximum fluence 1.9 J/cm2 for 532-nm and 8.5 J/cm2 for 1064-nm handpieces | Only 26% of subjects were non-Caucasian | 34 (34 subjects with 39 tattoos) | 86% (31 of 36 tattoos) showed at least a 50% clearance after three treatments. Patient satisfaction and treatment tolerability were high. | Adverse events were few and transient in nature. |
Sirithanabadeekul et al. [47] | RCT | 2022 | Fractionated 1064-nm picosecond lasers and unfractional 1064-nm ps-laser | 1064-nm ps-laser: fluence 1.5–7.24 J/cm2; 3–4.5 mm spot, 2–5 Hz; fractionated 1064-nm ps-lasers: fluence 0.8 J/cm2; 8 mm spot, 2–5 Hz | III–V | 11 | The combination side showed greater clearance scores and fewer adverse events than the side of unfractional 1064-nm picosecond laser alone. | Temporary crusting, purpura, edema, erythema, burning sensation, and petechiae |
/ Refers to details not mentioned in study.